JP2010538054A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538054A5
JP2010538054A5 JP2010523589A JP2010523589A JP2010538054A5 JP 2010538054 A5 JP2010538054 A5 JP 2010538054A5 JP 2010523589 A JP2010523589 A JP 2010523589A JP 2010523589 A JP2010523589 A JP 2010523589A JP 2010538054 A5 JP2010538054 A5 JP 2010538054A5
Authority
JP
Japan
Prior art keywords
lipoteichoic acid
pharmaceutical composition
pneumothorax
combination
pleural effusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010523589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538054A (ja
JP5623906B2 (ja
Filing date
Publication date
Priority claimed from GBGB0717442.8A external-priority patent/GB0717442D0/en
Application filed filed Critical
Publication of JP2010538054A publication Critical patent/JP2010538054A/ja
Publication of JP2010538054A5 publication Critical patent/JP2010538054A5/ja
Application granted granted Critical
Publication of JP5623906B2 publication Critical patent/JP5623906B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010523589A 2007-09-07 2008-09-08 胸水貯留または気胸の処置において使用するためのリポテイコ酸を含む組成物 Expired - Fee Related JP5623906B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0717442.8 2007-09-07
GBGB0717442.8A GB0717442D0 (en) 2007-09-07 2007-09-07 Compositions and uses thereof
PCT/GB2008/003019 WO2009030929A1 (en) 2007-09-07 2008-09-08 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax

Publications (3)

Publication Number Publication Date
JP2010538054A JP2010538054A (ja) 2010-12-09
JP2010538054A5 true JP2010538054A5 (enExample) 2011-10-27
JP5623906B2 JP5623906B2 (ja) 2014-11-12

Family

ID=38640413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523589A Expired - Fee Related JP5623906B2 (ja) 2007-09-07 2008-09-08 胸水貯留または気胸の処置において使用するためのリポテイコ酸を含む組成物

Country Status (8)

Country Link
US (1) US8536139B2 (enExample)
EP (1) EP2194991B1 (enExample)
JP (1) JP5623906B2 (enExample)
CN (1) CN101801392B (enExample)
AT (1) ATE545424T1 (enExample)
ES (1) ES2382501T3 (enExample)
GB (1) GB0717442D0 (enExample)
WO (1) WO2009030929A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8611854U1 (de) 1986-04-30 1986-06-19 Stahl Gmbh & Co Maschinenfabrik, 7140 Ludwigsburg Kombinierte Vierbruchfalzmaschine
EP2545909A1 (en) * 2011-07-12 2013-01-16 Lunamed AG Combination of D-Amino Acids and Lipoteichoic Acid
EP2589387A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain
EP2589388A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a Teichoic acid for the treatment of malignant ascites
CN103961512A (zh) * 2014-06-02 2014-08-06 王志红 一种用于创伤性气胸护理的中药制剂及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2208780C (en) * 1995-01-30 2010-03-30 Peter Truog Antitumor and anticholesterol preparations comprising lipoteichoic acid lta-t of streptococcus sp dsm 8747
US20050163764A1 (en) 2003-09-22 2005-07-28 Yale University Treatment with agonists of toll-like receptors
US20100256085A1 (en) 2006-10-16 2010-10-07 Yale University Toll-Like Receptor Agonist Regulation of VEGF-Induced Tissue Responses

Similar Documents

Publication Publication Date Title
WO2011099832A3 (en) Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
JP2015512418A5 (enExample)
JP2010222367A5 (enExample)
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
CL2013001136A1 (es) Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional.
EP3682875A3 (en) Methods of treating pediatric metabolic syndrome
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
HN2011001280A (es) Compuestos de arilo con sustituyentes heterociclicos y su uso
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
NZ747657A (en) Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
HK1198869A1 (en) Combination treatments for hepatitis c
EA201491358A1 (ru) Вводимые перорально кортикостероидные композиции
ECSP17000643A (es) Combinación farmacéutica que comprende 3-(3-dimetilamino-1etil-2-metil-propil)-fenol y Paracetamol.
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
JP2013541583A5 (enExample)
WO2015038552A3 (en) Aspirin formulation for increased efficacy
CL2014003503A1 (es) Composición farmacéutica para uso intramamario que comprende un ácido fosfónico y al menos un agente antimicrobiano; y uso para el tratamiento o prevención de mastitis en mamífero no humano.
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
JP2015535291A5 (enExample)
CL2012001940A1 (es) Composiciones que comprenden extractos de andrographis paniculata combinados con extractos de ginkgo biloba complejados con fosfolípidos; y su uso en la preparación de un medicamento para el tratamiento de alzheimer y esclerosis múltiple.
JP2007119497A5 (enExample)
JP2013520447A5 (enExample)
JP2017061488A5 (enExample)
HK1222585A1 (zh) 用於提供疼痛减轻和麻醉的二氢埃托啡